E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/29/2016 in the Prospect News Structured Products Daily.

New Issue: UBS prices $5.65 million airbag autocallables linked to Celgene

By Marisa Wong

Morgantown, W.Va., Sept. 29 – UBS AG, London Branch priced $5.65 million of 7.3% airbag autocallable yield notes due Oct. 4, 2017 linked to the common stock of Celgene Corp., according to a 424B2 filing with the Securities and Exchange Commission.

Interest is payable monthly.

If the stock closes at or above its initial price on a quarterly observation date, the notes will be automatically called at par plus the coupon.

If the notes are not called and the stock finishes at or above the conversion level, 88% of the initial price, the payout at maturity will be par. If the stock finishes below the conversion level, investors will receive a number of shares of Celgene stock equal to $1,000 divided by the initial share price.

UBS Financial Services Inc. and UBS Investment Bank are the agents.

Issuer:UBS AG, London Branch
Issue:Airbag autocallable yield notes
Underlying stock:Celgene Corp. (Symbol: CELG)
Amount:$5,648,000
Maturity:Oct. 4, 2017
Coupon:7.3%, payable monthly
Price:Par of $1,000
Payout at maturity:If the stock finishes at or above the conversion level, par; otherwise, 10.3842 shares of Celgene stock
Call:Automatically at par plus the coupon if the stock closes at or above its initial price on a quarterly observation date
Initial price:$109.43
Conversion level:$96.30, 88% of initial price
Pricing date:Sept. 23
Settlement date:Sept. 28
Agents:UBS Financial Services Inc. and UBS Investment Bank
Fees:1.5%
Cusip:90275Y450

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.